Author:
Su Tingting,Lai Sanchuan,Lee Allen,He Xingkang,Chen Shujie
Funder
the National Natural Science Foundation of China
Zhejiang province key science and technology innovation team
the Zhejiang Provincial Medical and health research plan
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Corleto VD, Festa S, Di Giulio E, et al. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes. 2014;21(1):3–8.
2. Bartholow M. Top 200 prescription drugs of 2009. Pharmacy Times. 2010. http://www.pharmacytimes.com/publications/issue/2010/may2010/rxfocustopdrugs-0510 .
3. Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf. 2010;19(10):1019–24.
4. Batuwitage BT, Kingham JG, Morgan NE, et al. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007;83(975):66–8.
5. Ramirez E, Lei SH, Borobia AM, et al. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol. 2010;5(4):288–97.
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献